![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
![](/images/png/glyphicons-791-one-day.png)
[ Tue, Jul 26th 2016
] - WOPRAI
[ Tue, Jul 26th 2016
] - WOPRAI
[ Tue, Jul 26th 2016
] - WOPRAI
![](/images/png/glyphicons-791-one-day.png)
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
Michael King Initiated (SYRS) at Buy on, Jul 25th, 2016
Michael King of JMP Securities, Initiated "Syros Pharmaceuticals, Inc." (SYRS) at Buy on, Jul 25th, 2016.
Michael has made no other calls on SYRS in the last 4 months.
There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, all agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Fein of "HC Wainwright & Co." Initiated at Hold and Held Target at $100 on, Monday, July 18th, 2016